Type 2 Diabetes Medications That Induce Weight Loss
Mar 22, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. A predominant risk factor for type 2 diabetes is being overweight or obese, so weight loss goals while maintaining normal blood sugar levels are very important for some patients.
How Do GLP-1 Receptor Agonists, Like Ozempic or Mounjaro, Work?
Jun 14, 2024 · Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. Glucagon-like peptide-1 (GLP-1) is a hormone released when food is eaten to slow gastric emptying, the process by which food leaves the stomach, so that the body can absorb nutrients from food.
Oral and Transdermal Estrogen Dose Equivalents
ORAL AND TRANSDERMAL ESTROGEN DOSE EQUIVALENTS; ORAL ESTROGENS TRANSDERMAL ESTROGENS • Plasma estrogen peaks & troughs • First pass through GI tract & liver
Diabetic Ketoacidosis (DKA) - Endocrinology Advisor
Apr 2, 2024 · Diabetic ketoacidosis (DKA) is an acute complication of diabetes that results from absolute or relative insulin deficiency. 1,2 It is characterized by the presence of metabolic acidosis, ketonemia, and hyperglycemia. 2 With prompt treatment, most patients with DKA recover, but in rare cases, such as patients who develop cerebral edema or have an underlying illness, DKA can become life ...
Gender-Affirming Surgery Rare Among Transgender Children in US
Aug 2, 2024 · Among children and adolescents, 16.8% were aged 15 to 17 years, 11.9% were aged 13 to 14 years, and 71.3% were aged 12 years and younger. The rate of gender-affirming surgery among TGD individuals was 5.3 per 100,000 adults, 2.1 per 100,000 adolescents aged 15 to 17 years, 0.1 per 100,000 adolescents aged 13 to 14 years, and 0 among children aged 12 years and younger.
How Should High Lipoprotein(a) Levels Be Addressed?
Oct 29, 2019 · Lipoprotein (a) (Lp[a]) is a known causal risk factor for cardiovascular (CV) disease, but on an international level, published guidelines differ in recommendations for its use in clinical settings to estimate or modify CV risk.To summarize key strategies for Lp(a) management, HEART UK published a consensus statement in Atherosclerosis outlining recommendations for Lp(a) measurement and ...
Hypercalcemia - Endocrinology Advisor
Nov 17, 2022 · Hypercalcemia Causes & Presentation. Hypercalcemia is a condition in which the calcium level in your blood is above normal. The normal range of calcium is 8.5 to 10.5 mg/dl (4.3 to 5.3 mEq/L or 2.2 to 2.7 mmol/L). 1 This reference range may differ by 0.5 mg/dl depending on the laboratory or hypercalcemia workup. Patients typically present with symptoms of hypercalcemia when the serum calcium ...
Sellar Mass - Endocrinology Advisor
Dec 7, 2022 · History & Epidemiology. Sellar masses (SMs) are adenoma bodies that are typically located on or around the pituitary gland, specifically near the sella turcica. 1,2 Sellar masses are known to account for approximately 10% to 15% of all intracranial neoplasms. 3,4 and are responsible for a myriad of visual, neurological, and hormonal deficiencies. 3 Pituitary adenomas (PAs) account for the vast ...
Central Hypothyroidism - Endocrinology Advisor
Nov 17, 2022 · History & Epidemiology of Central Hypothyroidism. Hypothyroidism may be defined as primary, secondary, or tertiary hypothyroidism. Primary hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormone.
Thyroid Hormone Resistance - Endocrinology Advisor
Nov 17, 2022 · Etiology & Risk Factors for Thyroid Hormone Resistance. Impaired sensitivity is due to mutations in the thyroid hormone receptor. Thyroid hormone levels are determined by the concentrations of thyrotropin-releasing hormone (TRH), secreted by the hypothalamus, and thyroid-stimulating hormone (TSH), secreted by the anterior pituitary gland. The two types of thyroid hormone are 3,3’triiodo-L ...